These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16169724)

  • 1. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation.
    Vijaya Bhaskar Reddy M; Tsai WJ; Qian K; Lee KH; Wu TS
    Bioorg Med Chem; 2011 Dec; 19(24):7711-9. PubMed ID: 22055718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
    Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
    Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
    Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
    Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
    Huang WH; Lee AR; Chien PY; Chou TC
    J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines.
    Ramajayam R; Giridhar R; Yadav MR; Balaraman R; Djaballah H; Shum D; Radu C
    Eur J Med Chem; 2008 Sep; 43(9):2004-10. PubMed ID: 18191304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone.
    Lee HS
    Bioresour Technol; 2006 Aug; 97(12):1372-6. PubMed ID: 16112857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
    Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
    Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
    Ferlin MG; Borgo C; Deana R
    Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
    Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
    Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
    Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
    Rehse K; Baselt T
    Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-platelet activity of obovatol derivatives.
    Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
    Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.